Mary M Gooley Hemophilia Center Inc

Learn about this cause: Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 160836536 ✦ Rochester, NY ✦ Designated as a 501(c)(3)

Overview

What is Mary M Gooley Hemophilia Center Inc?

Mary M Gooley Hemophilia Center Inc, located in Rochester, New York, is a nonprofit organization dedicated to providing comprehensive care and home infusion services for individuals with bleeding disorders, such as hemophilia, Von Willebrand disease, and other related conditions. With an active caseload of approximately 392 patients, the center treated and evaluated 224 unique patients in 2022. To ensure optimal care, 56 of these patients attend specialized clinics yearly, where they receive consultations from onsite specialists, including hematologists, nurse coordinators, social workers, physical therapists, orthopedic surgeons, and dentists. The organization boasts an on-site specialty pharmacy that delivers clotting factor to 59 hemophilia patients via its home infusion program. The mission of Mary M Gooley Hemophilia Center Inc encompasses education, treatment, research, advocacy, and supportive programs to enhance the lives of individuals battling bleeding disorders and iron overload. The organization employs a team of ten individuals to carry out its mission.


Official website here: www.hemocenter.org

Is Mary M Gooley Hemophilia Center Inc legitimate?

Mary M Gooley Hemophilia Center Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Mary M Gooley Hemophilia Center Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.

Here are some key statistics you may want to consider:

Executive Compensation: $585,556
Professional Fundraising Fees: $0
Other Salaries and Wages: $372,381

For more financial information, click here


Official website here: www.hemocenter.org

What is the mission statement of Mary M Gooley Hemophilia Center Inc?

The Mary M Gooley Hemophilia Center Inc is dedicated to enhancing the lives of individuals dealing with bleeding disorders and iron overload. Through its various programs, the organization offers education, treatment, research, advocacy, and support. In 2022, 224 unique patients, including those with hemophilia, Von Willebrand disease, and other rare clotting deficiencies, were evaluated and treated. The center provides specialized care for moderate and severe hemophilia patients, with consultations from specialists such as hematologists, nurse coordinators, social workers, physical therapists, orthopedic surgeons, and dentists. The organization runs an on-site specialty pharmacy that administers clotting factor to 59 hemophilia patients through its home infusion program.


Official website here: www.hemocenter.org

Who is the CEO of Mary M Gooley Hemophilia Center Inc?

Thomas Wilmarth is the Board Member of Mary M Gooley Hemophilia Center Inc. The CEO's salary of Mary M Gooley Hemophilia Center Inc is $200,172 and their total compensation is $177,367.


Official website here: www.hemocenter.org

What is the revenue of Mary M Gooley Hemophilia Center Inc?

Mary M Gooley Hemophilia Center Inc's revenue in 2022 was $23,562,520.


Official website here: www.hemocenter.org

Who are the executives of Mary M Gooley Hemophilia Center Inc and what are their salaries?

The average compensation at Mary M Gooley Hemophilia Center Inc during 2022 was $95,794. There are 10 employees and 11 volunteers at Mary M Gooley Hemophilia Center Inc.

Here are 12 key members and their salaries (Mary M Gooley Hemophilia Center Inc's CEO's salary is $200,172 and their total compensation is $177,367):

    Thomas Wilmarth (President & Ceo)
  • Compensation: $200,172
  • Related: $0
  • Other: $-22,805

    • Gregory Lighthouse Cpa (Cfo)
  • Compensation: $136,665
  • Related: $0
  • Other: $-13,663

    • Eric Iglewski Lmsw (Vp Of Clinical Services)
  • Compensation: $127,194
  • Related: $0
  • Other: $-14,355

    • Samantha Vitagliano Dmd (Chairperson) [Trustee/Director]
  • Compensation: $1,000
  • Related: $0
  • Other: $0

    • Akua Asante Md (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Khari Sabb (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Michael Scott-Kristansen Esq (Former Chairperson) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Dan Gurell (Treasurer) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Christine Hay Md (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Andrew Park (Secretary) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Larry Denk Md (Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0

    • Peter Kouides Md (Non-Voting Board Member) [Trustee/Director]
  • Compensation: $0
  • Related: $0
  • Other: $0


  • Official website here: www.hemocenter.org

    Where can I find the form 990 for Mary M Gooley Hemophilia Center Inc?

    The Mary M Gooley Hemophilia Center Inc’s most recent form 990 was submitted in 2022 and can be accessed here


    Official website here: www.hemocenter.org

    Learn more at the official website: www.hemocenter.org

    Mission Statement of Mary M Gooley Hemophilia Center Inc

    Mary M Gooley Hemophilia Center Inc is dedicated to improving the lives of individuals affected by bleeding disorders and iron overload. The nonprofit organization offers education, treatment, research, advocacy, and supportive programs to address the unique needs of those dealing with these conditions.

    Specifically, the Center provides comprehensive care to around 392 bleeding disorder patients, diagnosing and managing conditions like hemophilia, Von Willebrand disease, and other rare clotting deficiencies. In 2022, 224 unique patients received evaluations and treatments. Among them, 56 patients with moderate and severe hemophilia attend specialized clinics annually, benefiting from consultations with hematologists, nurse coordinators, social workers, physical therapists, orthopedic surgeons, and dentists.

    Moreover, Mary M Gooley Hemophilia Center Inc houses an on-site specialty pharmacy, providing clotting factor to 59 hemophilia patients through its home infusion program. By offering personalized care and convenient access to essential medications, the organization ensures that patients receive the best possible treatment for their conditions.

    Through its commitment to providing comprehensive support, Mary M Gooley Hemophilia Center Inc plays a crucial role in enhancing the quality of life for those dealing with bleeding disorders and iron overload.

    Impact

    This information is meant to be a general summary of Mary M Gooley Hemophilia Center Inc. Please take the time to review official sources before making any decisions based upon the content provided here.




    Thursday, August 15, 2024

    The impact of the Mary M Gooley Hemophilia Center Inc is significant in improving the lives of individuals affected by bleeding disorders and iron overload. The center provides essential services such as treatment, education, research, advocacy, and supportive programs aimed at addressing the needs of individuals with hemophilia and other related blood disorders.

    With approximately 392 bleeding disorder patients on its active caseload, the center plays a crucial role in evaluating and treating patients with hemophilia, Von Willebrand disease, and other rare clotting deficiencies. The specialized comprehensive care clinics at the center serve 56 patients with moderate and severe hemophilia, offering consultations from various healthcare professionals including hematology specialists, nurse coordinators, social workers, physical therapists, orthopedic surgeons, and dentists.

    Moreover, the on-site specialty pharmacy at the center provides clotting factor to 59 hemophilia patients through a home infusion program, ensuring access to necessary treatments and medications. Overall, the Mary M Gooley Hemophilia Center Inc's dedicated efforts contribute significantly to enhancing the quality of life for individuals affected by bleeding disorders in the Rochester, NY area.





    Financials

    This financial information is from Propublica.

    Revenue
    Expenses
    Efficiency

    Other financial information:

    This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $481,898
  • Program Service Revenue: $22,979,606
  • Gross Receipts: $24,254,933

    • Assets and Liabilities:
  • Total Assets: $22,291,698
  • Total Liabilities: $3,721,514
  • Net Assets: $18,570,184
  • Programs

    Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.

    HEMOPHILIA & OTHER BLEEDING DISOR

    Revenue

    $22,922,768

    HEMOCHROMATOSIS

    Revenue

    $56,838

    Organization Details

    Founding Year

    1959

    Principal Officer

    Thomas Wilmarth

    Main Address

    1415 PORTLAND AVE 500, ROCHESTER, NY, 14621

    NTEE Category

    Code: G20 - Disease

    If you are a representative of Mary M Gooley Hemophilia Center Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.